Details of the Drug Formulations

General Information of Drug (ID: DMW5ML9)

• Drug Name: Tecovirimat Drug Info
• Synonyms: Tecovirimat; ST 246; SIGA-246; UNII-F925RR824R; 816458-31-8; F925RR824R; ST-246; TPOXX; Tecovirimat [USAN:INN]; SIGA 246

Indication

Disease Entry	ICD 11	Status	REF
Smallpox	1E70	Approved	[1]
Virus infection	1A24-1D9Z	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 16124688
  CAS Number: 869572-92-9
  TTD ID: D0MD8D
  ACDINA ID: D01467

Full List of Drug Formulations Containing This Drug

Tecovirimat 200 mg capsule

Company	Formulation ID	FDA Description
Siga Technologies	F23301	Colloidal Silicon Dioxide; Croscarmellose Sodium; Hydroxypropyl Methyl Cellulose; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Sodium Lauryl Sulfate; Gelatin; Fd&C Blue 1; Fd&C Red 3; Fd&C Yellow 6; Titanium Dioxide

References

• [1] Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.IDrugs. 2010 Mar;13(3):181-91. Review
• [2] ClinicalTrials.gov (NCT02474589) A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat.